Request for Covid-19 Impact Assessment of this Report
End Users
The end users of glucose monitoring devices are mainly hospitals, laboratories and individual customers. Hospitals and laboratories usually use sophisticated and highly accurate glucose monitoring devices. On the other hand, individual customers mainly use compact and low cost glucose monitoring devices. Adoption of new technologies that allow for non-invasive glucose monitoring is expected to further boost the market.
Market Dynamics
Increasing prevalence of diabetes related medical conditions and the growing awareness about the importance of glucose monitoring are the primary growth drivers of the glucose monitoring devices market. Availability of highly portable and easy to use products has helped the individual customers segment to grow at rapid pace. Adoption of new technology that promises painless and non-invasive glucose monitoring is expected to further boost growth of the market. Continuous glucose monitoring devices market is expected to witness faster growth due to the potential of gaining much better insight to the patient's reaction to glucose levels.
Some of the restraints faced by the market are high operating costs of blood glucose monitoring devices and accessibility issues with continuous glucose monitoring devices. Also, incorrect use of the devices may result in inaccurate results which can hurt customer trust in the devices. Thus companies need to introduce products that are easy to use and also ensure that the end user is trained to use the product.
Market Segmentation
The global glucose monitoring devices market can be segmented based on type of device, type of method used to measure glucose, type of end user and geography. Based on type of device, the market can be segmented as blood glucose monitoring and continuous glucose monitoring devices. A new type called non-invasive glucose monitoring device is also gaining ground in the market. Based on method used to measure glucose, the market can be segmented as strips, lancet, electrode, and others.
Regional/Geographic Analysis
Geographically, the glucose monitoring devices market can be divided into North America, Europe, Asia-Pacific (APAC), and Latin America, Middle East and Africa (LAMEA) regions. Currently, North America accounts for the largest share of the market. Fast growth is expected in the APAC region due to high population, prevalence of lifestyle diseases, rising awareness and increasing disposable incomes.
Key Players
Some of the key players in the glucose monitoring devices market are Roche Diagnostics, LifeScan, Bayer Healthcare Division, Arkray, and Abbott Laboratories.
The report contains comprehensive analysis on:
--> Glucose Monitoring Devices Market Segments
--> Glucose Monitoring Devices Market Drivers, Restraints and Opportunities
--> Glucose Monitoring Devices Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Glucose Monitoring Devices Market Current Trends
--> Competition &Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Glucose Monitoring Devices Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...